ucsf logo

Drug safety is the aim of UCSF-Optivia research partnership

Pharmacogenetics expert Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences, is leading the UCSF arm of a research partnership in which her team will profile 2,000 prescription drugs against key molecules in the liver and kidney that are responsible for ferrying those drugs across the cell membrane and into the cell. MoreDrug safety is the aim of UCSF-Optivia research partnership

Tags: 
Optivia Biotechnology
pharmacogenetics
membrane transporters
prescription drugs
partnership
Key people: 
Kathy Giacomini

Next topic: About QBC